Anatomy of a Deal

For individuals that are either new to the pharmaceutical industry or the disciplines of biopharma dealmaking, the process of how a licensing deal emerges and subsequently gets signed might not be that obvious.

Partnering in China

The Chinese pharmaceutical industry is growing, both in terms of the size of the market for Western-style medicines versus traditional Chinese medicines and the number of companies now active in developing Western-style medicines.

Partnering in Europe

When considering the costs for a European partnership there are the short-term costs related to the transaction process and the longer-term costs related to losing control of your product in the licensed territory.

Your BD Strategy

If you are an emerging biotech company focusing on out-licensing, the following seven steps are designed to empower dealmakers with proven, actionable guidelines, to creating a business development strategy.